TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

LATEST NEWS

'Free the Webcast!' Investor Transparency Gains Momentum at 'JPM15' Healthcare Confab
STOCKS

Biotech Stocks Are Selling Off Just Like 2014 -- and That Might Be a Good Thing

Drug Giant Eli Lilly Wants to Save Money So it Brought in These New Bigwigs
MERGERS AND ACQUISITIONS

Valeant Boosts Offer for Salix to $15.8 Billion, Endo Drops Bid

Concordia Healthcare Acquires Covis Pharma for $1.2 Billion in Cash
MERGERS AND ACQUISITIONS

Concordia Healthcare Acquires Covis Pharma for $1.2 Billion in Cash

Germany's Merck Lifts Full-Year Guidance After Sigma-Aldrich Boosts Sales
MERGERS AND ACQUISITIONS

Biotechs and Drugmakers Expected to Seek More Mergers in 2015

'Mad Money' Lightning Round: Buy, Buy, Buy CBS When Stock Comes Down
JIM CRAMER

'Mad Money' Lightning Round: Ambarella Is Like Putting a Gun to Your Head

Cramer: $45 a Barrel Oil Is a 'Must-Hold' Level for Many Producers
JIM CRAMER

Jim Cramer's 'Mad Money' Recap: Zombie Stocks That Will Rise From the Dead

Jim Cramer's Top Stock Picks: WFC DD MS AGEN
OPINION

Jim Cramer's Top Stock Picks: ISIS CELG NPSP AA ACOR

Jim Cramer's 'Mad Money' Recap: Blame Tech, Oil and Retail for Today's Losses
JIM CRAMER

Jim Cramer's 'Mad Money' Recap: Blame Tech, Oil and Retail for Today's Losses

Shire's Takeover of NPS Pharmaceuticals: What Wall Street's Saying
INVESTING

Shire's Takeover of NPS Pharmaceuticals: What Wall Street's Saying

June 26 Premarket Briefing: 10 Things You Should Know
MARKETS

Stocks Sink as Wall Street 'Fixates' on Stabilization in Oil Prices

Will Amazon.com (AMZN) Stock be Affected by New E-Book Author Royalty Plan?
MARKETS

Jim Cramer Explains Why Shire's Purchase of NPS Pharmaceuticals (NPSP) is Important

Ex-Dividend Alert: 3 Stocks Going Ex-Dividend Tomorrow: SBW, HIO, ETG
MARKETS

3 Stocks Moving The Health Care Sector Upward

Stocks Fluctuate as Oil Pares Losses, Greek Talks Continue
MARKETS

Stocks Are Falling as Oil Prices Crumble to New 5-Year Low

Continental Resources (CLR) Stock Rises Today as Oil Prices Rally
MARKETS

NPS Pharmaceuticals (NPSP) Stock Spikes Today After Agreeing to Acquisition

Shire Agrees to Pay $5.2 Billion for NPS Pharmaceuticals
MERGERS AND ACQUISITIONS

Shire Agrees to Pay $5.2 Billion for NPS Pharmaceuticals

Don't Panic! Despite First-Quarter Fears, U.S. Economic Expansion Won't End Soon
MARKETS

Stock Futures Recover From Friday’s Jobs Growth Jitters

Insider Trading Alert - AEL, ANIP And CRM Traded By Insiders
MARKETS

Heavy Early Morning Activity On NPS Pharmaceuticals (NPSP)

New York Slideshow: 9/11 and After
STOCKS

January 12 Premarket Briefing: 10 Things You Should Know

European Stocks Subdued on Volkswagen Power Struggle, Roaring Asian Stocks
MARKETS

European Stocks Rebound as Pharma Deals Renew Confidence

Looking at Mannkind's Afrezza Sales Estimates Ahead of Sanofi Earnings
STOCKS

Tale of 2 Rare Disease Stocks: Aegerion, NPS Pharmaceuticals

Genfit Digs Even Deeper to Find Hidden Benefit in Fatty Liver Drug
STOCKS

Biotech Investors Guide and Preview to the J.P. Morgan Healthcare Conference Part 1

Shire Agrees to Pay $5.2 Billion for NPS Pharmaceuticals
MERGERS AND ACQUISITIONS

Orphan Drug Company NPS Pharmaceuticals May Find Few Buyers

Merck Faces Hep C Pricing Dilemma to Counter Gilead, Abbvie
STOCKS

Fifteen Fabulously Intelligent Biotech Stock Predictions for 2015

Today's Weak On High Volume Stock: Ocean Rig UDW (ORIG)
MARKETS

Barbarian At The Gate: NPS Pharmaceuticals (NPSP)

Insider Trading Alert - AEL, ANIP And CRM Traded By Insiders
MARKETS

NPS Pharmaceuticals (NPSP) Marked As A Barbarian At The Gate